dr. moore on treatment for patients with ovarian cancer who develop resistance to parp inhibitors
Published 4 years ago • 147 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer
-
2:32
dr. moore on research evaluating repeat exposure to parp inhibition in ovarian cancer
-
1:40
dr. moore on immunotherapy and parp combinations in brca-mutated ovarian cancer
-
1:41
dr. moore on benefit of mirvetuximab soravtansine in patients with ovarian cancer
-
2:09
dr. moore on the nova trial for ovarian cancer
-
7:57
prepping patients with advanced oc for parp inhibition
-
6:25
combinations with parp inhibitors for ovarian cancer
-
1:34
dr. moore on challenges with immunotherapy in ovarian cancer
-
21:52
esmo 2018: dr. moore speaks to exciting parp inhibitor abstracts in ovarian cancer
-
5:28
ongoing parp inhibitor research in ovarian cancer
-
1:22
overcoming resistance to parp inhibition in ovarian cancer
-
2:19
dr. moore on anticipated impact of the mirasol trial in platinum-resistant ovarian cancer
-
1:51
kathleen n. moore discusses new parp inhibitors for ovarian cancer
-
1:49
dr. moore on safety profile of mirvetuximab soravtansine in ovarian cancer
-
1:38
dr. chase on niraparib as frontline maintenance therapy in ovarian cancer
-
1:25
dr. emens on the combination of checkpoint inhibitors and parp inhibitors in ovarian cancer
-
7:38
parp maintenance therapy in recurrent ovarian cancer
-
3:25
ovarian cancer: recurrence after parp inhibition
-
6:20
parp inhibitors in recurrent ovarian cancer